William C. Hahn
9Patents
1h-index
29Co-inventors
51Inventor score
Filing activity: Oct 29, 1999 → Sep 4, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8178317B2 | Compositions and methods for identifying transforming and tumor suppressor genes | Chemistry; Metallurgy | 4 | Active |
| US10426774B2 | Methods of treating cancer having an active Wnt/β-catenin pathway | Physics | 1 | Active |
| US7851591B1 | Cancer immunotherapy and diagnosis using universal tumor associated antigens, including hTERT | Human Necessities | 1 | Expired |
| US8637260B2 | Phosphorylated RaIA | Physics | 0 | Active |
| US11492670B2 | Compositions and methods for targeting cancer-specific sequence variations | Chemistry; Metallurgy | 0 | Active |
| US12152008B2 | Cyclopentaimidazolones for the treatment of cancer | Human Necessities | 0 | Active |
| US9593377B2 | Signatures and determinants associated with cancer and methods of use thereof | Physics | 0 | Active |
| US12282014B2 | Methods of identifying compounds that interfere with ERG-driven misguidance of BAF complexes in TMPRSS2-ERG driven prostate cancers | Physics | 0 | Active |
| US12109212B2 | Methods of treating cancer having an active Wnt/β-catenin pathway | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.